AR099432A1 - P38 MAP QUINASA INHIBITORS - Google Patents
P38 MAP QUINASA INHIBITORSInfo
- Publication number
- AR099432A1 AR099432A1 ARP150100447A ARP150100447A AR099432A1 AR 099432 A1 AR099432 A1 AR 099432A1 AR P150100447 A ARP150100447 A AR P150100447A AR P150100447 A ARP150100447 A AR P150100447A AR 099432 A1 AR099432 A1 AR 099432A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- salt
- map
- quinasa
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 6
- 150000003839 salts Chemical class 0.000 abstract 4
- 229940122696 MAP kinase inhibitor Drugs 0.000 abstract 1
- 125000006242 amine protecting group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 abstract 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 abstract 1
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee un compuesto inhibidor de p38 MAP quinasa para utilizar como medicamento para el tratamiento inter alia de enfermedades inflamatorias. Reivindicación 1: Un compuesto de fórmula (1) o una sal farmacéuticamente aceptable del mismo. Reivindicación 16: Un compuesto de fórmula (2) o un derivado del mismo en el cual el grupo amino está protegido, o una sal del mismo. Reivindicación 17: Un compuesto de fórmula (3) o una sal del mismo. Reivindicación 18: Un compuesto de fórmula (2) de acuerdo con la reivindicación 16 el cual es un compuesto de fórmula (4) donde P¹ representa un grupo protector de amina; o una sal del mismo.A p38 MAP kinase inhibitor compound is provided for use as a medicament for the inter alia treatment of inflammatory diseases. Claim 1: A compound of formula (1) or a pharmaceutically acceptable salt thereof. Claim 16: A compound of formula (2) or a derivative thereof in which the amino group is protected, or a salt thereof. Claim 17: A compound of formula (3) or a salt thereof. Claim 18: A compound of formula (2) according to claim 16 which is a compound of formula (4) wherein P¹ represents an amine protecting group; or a salt thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461940282P | 2014-02-14 | 2014-02-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR099432A1 true AR099432A1 (en) | 2016-07-20 |
Family
ID=58699447
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150100447A AR099432A1 (en) | 2014-02-14 | 2015-02-13 | P38 MAP QUINASA INHIBITORS |
| ARP150100448A AR099433A1 (en) | 2014-02-14 | 2015-02-13 | DERIVATIVES OF PIRAZOL UREA |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150100448A AR099433A1 (en) | 2014-02-14 | 2015-02-13 | DERIVATIVES OF PIRAZOL UREA |
Country Status (1)
| Country | Link |
|---|---|
| AR (2) | AR099432A1 (en) |
-
2015
- 2015-02-13 AR ARP150100447A patent/AR099432A1/en active IP Right Grant
- 2015-02-13 AR ARP150100448A patent/AR099433A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AR099433A1 (en) | 2016-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| CO2019005165A2 (en) | Pyridone compound as c-met inhibitor | |
| CO2021005532A2 (en) | Quinoline derivatives as inhibitors of integrin alpha4beta7 | |
| NZ736709A (en) | Benzimidazole and imidazopyridine carboximidamide compounds having activity as inhibitors of indoleamine 2,3-dioxygenase | |
| EA201791576A1 (en) | JAK INHIBITOR | |
| MX2018000396A (en) | Substituted aza compounds as irak-4 inhibitors. | |
| MX2016001400A (en) | 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions. | |
| DOP2015000201A (en) | AZABENCIMIDAZOL COMPOUNDS AS INHIBITORS OF PDEN4 ISOENZIMAS FOR THE TREATMENT OF THE CNS AND OTHER DISORDERS | |
| MX2016013265A (en) | Analogues of 4h-pyrazolo[1,5-î]benzimidazole compound as parp inhibitors. | |
| EA201590224A1 (en) | IMIDAZOTRIASINCARBONITRILE USED AS KINASE INHIBITORS | |
| AR103680A1 (en) | BACE1 SELECTIVE INHIBITORS | |
| CU20160192A7 (en) | INDANO AND INDOLINA DERIVATIVES USEFUL AS ACTIVATORS OF THE SOLUBLE CYCLING GUANILATE | |
| PE20180412A1 (en) | INHIBITING COMPOUNDS OF THE NOTCH WAY SIGNALING | |
| PH12016501462A1 (en) | Neprilysin inhibitors | |
| MX2018001992A (en) | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors. | |
| CU24434B1 (en) | COMPOUNDS DERIVED FROM N- (1,5-DIMETHYL-3-OXO-2,3-DIHYDRO-1H-PIRAZOL-4-IL) -4-METHYL-5-ISOXAZOLE-3-CARBOXAMIDE ACTIVE AS SELECTIVE INHIBITORS OF SMURF-1 | |
| AR105821A1 (en) | USEFUL COMPOUNDS TO INHIBIT ROR-g-T | |
| CO2019001644A2 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
| UY36123A (en) | CARBOXAMIDE DERIVATIVES | |
| MX386902B (en) | METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS. | |
| AR099432A1 (en) | P38 MAP QUINASA INHIBITORS | |
| AR105400A1 (en) | JAK1 INHIBITORS | |
| SV2016005317A (en) | DERIVATIVES OF PIRROLIDINE -2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE AS IDO1 INHIBITORS | |
| AR108363A1 (en) | TETRAHYDROFUROOXAZINE COMPOUNDS AND ITS USE AS SELECTIVE BACE1 INHIBITORS | |
| CU20160170A7 (en) | CARBOXAMIDE DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |